These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20853900)

  • 1. Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.
    Crane CM; Pierce JG; Leung SS; Tirado-Rives J; Jorgensen WL; Boger DL
    J Med Chem; 2010 Oct; 53(19):7229-35. PubMed ID: 20853900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of methyl ether derivatives of the vancomycin, teicoplanin, and ristocetin aglycon methyl esters.
    McComas CC; Crowley BM; Hwang I; Boger DL
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2933-6. PubMed ID: 14611861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid.
    Crane CM; Boger DL
    J Med Chem; 2009 Mar; 52(5):1471-6. PubMed ID: 19209892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Xie J; Okano A; Pierce JG; James RC; Stamm S; Crane CM; Boger DL
    J Am Chem Soc; 2012 Jan; 134(2):1284-97. PubMed ID: 22188323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.
    Pinchman JR; Boger DL
    J Med Chem; 2013 May; 56(10):4116-24. PubMed ID: 23617725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver(I)-promoted conversion of thioamides to amidines: divergent synthesis of a key series of vancomycin aglycon residue 4 amidines that clarify binding behavior to model ligands.
    Okano A; James RC; Pierce JG; Xie J; Boger DL
    J Am Chem Soc; 2012 May; 134(21):8790-3. PubMed ID: 22568755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives.
    Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS
    Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
    Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation into the functional impact of the vancomycin C-ring aryl chloride.
    Pinchman JR; Boger DL
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4817-9. PubMed ID: 23880541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
    Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
    ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin.
    Printsevskaya SS; Solovieva SE; Olsufyeva EN; Mirchink EP; Isakova EB; De Clercq E; Balzarini J; Preobrazhenskaya MN
    J Med Chem; 2005 Jun; 48(11):3885-90. PubMed ID: 15916441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the protein targets of vancomycin in living S. aureus and E. faecalis cells.
    Eirich J; Orth R; Sieber SA
    J Am Chem Soc; 2011 Aug; 133(31):12144-53. PubMed ID: 21736328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Crowley BM; Boger DL
    J Am Chem Soc; 2006 Mar; 128(9):2885-92. PubMed ID: 16506767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
    Chiosis G; Boneca IG
    Science; 2001 Aug; 293(5534):1484-7. PubMed ID: 11520986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
    Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.
    Okano A; Nakayama A; Wu K; Lindsey EA; Schammel AW; Feng Y; Collins KC; Boger DL
    J Am Chem Soc; 2015 Mar; 137(10):3693-704. PubMed ID: 25750995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.
    Nicolaou KC; Hughes R; Cho SY; Winssinger N; Labischinski H; Endermann R
    Chemistry; 2001 Sep; 7(17):3824-43. PubMed ID: 11575783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagine.
    McAtee JJ; Castle SL; Jin Q; Boger DL
    Bioorg Med Chem Lett; 2002 May; 12(9):1319-22. PubMed ID: 11965380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.